Italy
Ghènesis Biotech is a biotech company that aims to revolutionize various industries through the use of scientific methods and the extraction of plant compounds. Established in 2020, the company's philosophy revolves around utilizing the extraction of phytocomplexes from hemp for pharmaceutical and cosmetic purposes, as well as the extraction of cellulose derivatives for bioplastics and other applications, all contributing to a more sustainable and higher quality of life. Ghènesis Biotech collaborates with professionals from diverse sectors such as pharmaceuticals, construction, and food, leveraging their expertise to innovate and provide solutions for clients. Their approach involves meticulous research, adherence to a rigorous scientific method, publication in reputable scientific journals, testing, homologation, production, and commercialization both in Italy and internationally.
Operating with an unwavering commitment to ethical conduct, Ghènesis Biotech maintains high standards to ensure process efficiency, product integrity, employee safety, and environmental sustainability. While the headquarters location and specific details regarding the last investment and investors are not provided, the company’s comprehensive approach to biotechnology and dedication to ethical and sustainable practices position it as a promising venture for potential investment.
